Bladder cancer staging

Bladder cancer is a common tumour of the urinary tract, accounting for 6±8% of all male malignancies and 2±3% of all female malignancies [1,2]. In south-eastern England, there were 3000 new registrations in 1992 and over 2000 deaths were reported in 1994 [2]. Bladder cancer is generally considered a disease of later life, reaching a peak incidence in the sixth and seventh decades, although recent trends have revealed an increasing number of younger patients presenting with the disease [3]. The epidemiology of bladder cancer shows strong associations with some environmental factors. An increased incidence of bladder cancer was noted in those working with aniline dyes over 100 years ago. Since then, aromatic amines have been shown to be associated with the development of bladder cancer, introducing an occupational hazard for workers involved with organic chemicals, rubber and paint materials. Diesel fumes and long-term use of the analgesic phenacetin have also been implicated in the development of the disease [4]. Cigarette smoking has an important association with urothelial cancer; cigarette smokers are two to six times more likely to develop the disease than those who do not smoke [5,6]. Cystitis and chronic urinary tract infection predispose to bladder cancer, and < 7% of bladder tumours occur within diverticula. Where schistosomiasis is endemic, there is a high incidence of epithelial tumours, mostly of squamous cell type [7,8]. There is a genetic predisposition to the development of bladder cancer [9]. The clinical presentation of bladder cancer is classically with painless haematuria. Initial diagnostic manoeuvres do not involve imaging. Bacteriological and cytological examination of the urine frequently give signi®cant clues. Further investigation may be directed at the lower urinary tract, when cystoscopy is used. Imaging of the upper urinary tract involves a combination of crosssectional techniques and IVU. The vast majority of bladder tumours are epithelial in origin; of these < 90% are TCCs, the remainder being squamous cell carcinoma, adenocarcinoma and mixed tumours. A wide variety of nonepithelial tumours may affect the bladder. Leiomyosarcoma, rhabdomyosarcoma, phaeochromocytoma, hamartomatous malformations, lymphoma and metastases have been described. The imaging features of these rare tumours have been described only occasionally, but most present as a mass lesion which cannot be reliably discriminated from epithelial cancers using appearances on imaging alone. Of nonepithelial tumours, only lymphoma is suf®ciently common to be seriously considered in the differential diagnosis of a bladder wall mass. The other clinical circumstance which must be considered is that other pelvic tumours may invade directly into the bladder (e.g. carcinoma of the colorectal region, cervix and prostate). The imaging features of primary bladder tumours are essentially not speci®c; the diagnosis must always be con®rmed by cytology or histology, and imaging therefore plays a limited role at the time of diagnosis. Before computer-based cross-sectional imaging became available, mucosal lesions of the bladder could be detected with studies such as IVU, or cystography in which the bladder was ®lled with contrast medium, but the depth of invasion through the wall could not be assessed. With the advent of CT and ultrasonography (US) in the 1970s, and MRI in the 1980s, the penetration of epithelial tumours through the bladder wall can be depicted. Staging of tumours by imaging has become increasingly important in the management of bladder cancer as the available equipment has become more sophisticated. A variety of treatments now exist for bladder cancer and a rational choice is assisted by information from imaging studies. Accurate staging not only allows optimal treatment to be selected for the individual patient, but also allows valid comparisons to be made between different treatments given to patients with disease of similar stage. Some patients can still be staged by clinical means alone, but in most cases, some consideration should be given to the use of imaging as an adjunct.

[1]  C. Morgan,et al.  Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate. , 1981, Radiology.

[2]  A. Perkins,et al.  99mTechnetium‐C595 radioimmunoscintigraphy: a potential staging tool for bladder cancer , 2001, BJU international.

[3]  M. Caterino,et al.  Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques , 2001, Abdominal Imaging.

[4]  J. Richie,et al.  Biology and management of bladder cancer. , 1990, The New England journal of medicine.

[5]  A. Aisen,et al.  Staging of bladder carcinoma: MRI-CT-surgical correlation. , 1986, AJR. American journal of roentgenology.

[6]  H. R. Claypool,et al.  Recognition of bladder tumors by excretory urography. , 1981, Radiology.

[7]  H. Scher,et al.  Sonography in evaluation of carcinoma of bladder. , 1987, Urology.

[8]  J. Barentsz,et al.  Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences. , 1995, AJR. American journal of roentgenology.

[9]  P. Arger,et al.  CT staging of bladder carcinoma. , 1981, AJR. American journal of roentgenology.

[10]  S. Ishiguro,et al.  Bladder wall morphology: in vitro MR imaging-histopathologic correlation. , 1993, Radiology.

[11]  R Goldsmith,et al.  The epidemiology of bladder cancer. A second look , 1977, Cancer.

[12]  E. Franken,et al.  Urinary bladder tumors studied by cystosonography. Part I: Detection. , 1984, Radiology.

[13]  G. Prout,et al.  Ta and T1 bladder cancer: location, recurrence and progression. , 1982, British journal of urology.

[14]  G. Matanoski,et al.  Bladder cancer in young women. , 1986, American journal of epidemiology.

[15]  W. Kimberling,et al.  Familial bladder cancer in an oncology clinic. , 1987, Cancer genetics and cytogenetics.

[16]  M. Resnick,et al.  CT and MR imaging in staging bladder neoplasms. , 1987, Journal of computer assisted tomography.

[17]  R. Jeffrey,et al.  CT Evaluation of Invasive Lesions of the Bladder , 1981, Journal of computer assisted tomography.

[18]  R. Günther,et al.  Staging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful? , 1991, Journal of computer assisted tomography.

[19]  F. Seidelmann,et al.  Accuracy of CT staging of bladder neoplasms using the gas-filled method: report of 21 patients with surgical confirmation. , 1978, AJR. American journal of roentgenology.

[20]  A. Tanimoto,et al.  Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. , 1992, Radiology.

[21]  H. Denley,et al.  Imaging for staging bladder cancer: a clinical study of intravenous 111indium‐labelled anti‐MUC1 mucin monoclonal antibody C595 , 2001, BJU international.

[22]  J. Husband Staging bladder cancer. , 1992, Clinical radiology.

[23]  V. F. Marshall The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. , 1952, The Journal of urology.

[24]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[25]  P. Hartge,et al.  Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. , 1988, Cancer research.

[26]  J. Heiken,et al.  Primary bladder carcinoma: evaluation with MR imaging. , 1987, Radiology.

[27]  H. Bloom,et al.  Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. , 1982, British journal of urology.

[28]  N Karssemeijer,et al.  Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. , 1996, Radiology.

[29]  D. Hémon,et al.  Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco , 1989, International journal of cancer.

[30]  K. Kuriyama,et al.  Bladder tumors: staging with gadolinium-enhanced oblique MR imaging. , 1993, Radiology.

[31]  J. Husband,et al.  The role of computed tomography in the staging of bladder cancer. , 1979, Clinical radiology.

[32]  H. Bauer,et al.  Intravesical ultrasound tomography in staging bladder carcinoma. , 1982, The Journal of urology.

[33]  W. Whitmore,et al.  Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. , 1977, Transactions of the American Association of Genito-Urinary Surgeons.

[34]  J. Husband,et al.  Bladder cancer: staging with CT and MR imaging. , 1989, Radiology.

[35]  P. Carroll,et al.  Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. , 1994, Radiology.

[36]  Nick Engler,et al.  THE SECOND look. , 1954, Cancer bulletin.

[37]  H J JEWETT,et al.  Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases. , 1946, The Journal of urology.

[38]  B. Turner International Union Against Cancer (UICC) , 1999 .

[39]  M. Resnick,et al.  Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.

[40]  J. Husband,et al.  Contrast enhancing lymph nodes in bladder cancer: a potential pitfall on CT. , 1992, Clinical radiology.

[41]  O. Maeda,et al.  Stage specific follow‐up strategy after cystectomy for carcinoma of the bladder , 2002, International journal of urology : official journal of the Japanese Urological Association.

[42]  K. Sikora,et al.  Bladder cancer: inter-relationships between chemotherapy and radiotherapy. , 1992, British journal of urology.

[43]  D. Tolley,et al.  Results of surgery following radical radiotherapy for invasive bladder cancer. , 1986, British journal of urology.

[44]  A. Moss,et al.  MR staging of bladder carcinoma: correlation with pathologic findings. , 1988, Radiology.

[45]  J. Husband Review Staging Bladder Cancer , 1992 .

[46]  J. Barentsz,et al.  Carcinoma of the urinary bladder: MR imaging with a double surface coil. , 1988, AJR. American journal of roentgenology.

[47]  J. Witjes,et al.  Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. , 1996, AJR. American journal of roentgenology.

[48]  A. Tanimoto,et al.  Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography. , 1991, The Journal of urology.

[49]  J. Barentsz,et al.  The role of MR imaging in carcinoma of the urinary bladder. , 1993, AJR. American journal of roentgenology.

[50]  U. Nyman,et al.  New intravesical contrast medium for CT: preliminary studies with arachis (peanut) oil. , 1981, AJR. American journal of roentgenology.